Mental Attention-neuromuscular Training for Children With Developmental Coordination Disorder

NCT ID: NCT02397161

Last Updated: 2015-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

172 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To compare the effectiveness of EEG biofeedback mental attention-neuromuscular training (AT-NMT), neuromuscular training (NMT) alone, EEG biofeedback mental attention training (AT) alone, and no intervention for improving reactive balance performance among children with developmental coordination disorder (DCD).

Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothesis: The Investigators hypothesize that the reactive balance performance in children with DCD can be best improved by treating both their mental attention and neuromuscular deficits.

Objective: To compare the effectiveness of AT-NMT, NMT alone, AT alone, and no intervention for improving reactive balance performance among children with DCD.

Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.

Anticipated results and clinical significance: Children with DCD who receive AT-NMT will have the best reactive balance performance outcomes. If the results are positive, this novel training regime can be readily adopted in clinical practice. AT-NMT will improve overall well-being in these children and have positive socio-economic implications such as shorter rehabilitation periods and reduced healthcare costs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Coordination Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AT-NMT

AT-NMT group - will receive a 12-week EEG biofeedback mental attention-neuromuscular training

Group Type EXPERIMENTAL

EEG biofeedback mental attention-neuromuscular training

Intervention Type OTHER

Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises

NMT alone

NMT group - will receive a 12-week neuromuscular training

Group Type EXPERIMENTAL

Neuromuscular training

Intervention Type OTHER

Neuromuscular training using physio-therapeutic exercises

AT alone

AT group - will receive a 12-week EEG biofeedback mental attention training

Group Type EXPERIMENTAL

EEG biofeedback mental attention training

Intervention Type OTHER

Mental attention training using EEG biofeedback

Control

Control group - no intervention for 12 weeks

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EEG biofeedback mental attention-neuromuscular training

Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises

Intervention Type OTHER

Neuromuscular training

Neuromuscular training using physio-therapeutic exercises

Intervention Type OTHER

EEG biofeedback mental attention training

Mental attention training using EEG biofeedback

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 6 to 9 years old;
2. a formal diagnosis of DCD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) at a child assessment center;
3. a Bruininks-Oseretsky Test of Motor Proficiency giving a gross motor composite score of ≤42;
4. a Child Behavior Checklist attention problem subscale T score of ≥54.5, indicating an attention deficit;
5. attending a local mainstream school;
6. an intelligence level within the normal range; and
7. no experience in using the Brain Computer Interface system or similar apparatus.

Exclusion Criteria

1. a diagnosis of neurological or other movement disorder;
2. any cognitive, psychiatric (comorbid ADHD will not be excluded), congenital, musculoskeletal or cardiopulmonary disorder that can affect motor performance;
3. receiving active therapies or treatments including complementary and alternative medicine;
4. demonstrating excessive disruptive behavior; or
5. those unable to follow instructions adequately.
Minimum Eligible Age

6 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shirley S.M. Fong

Assistant Professor, DRPC chairperson

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shirley SM Fong, PT, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Hong Kong

Pokfulam, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shirley SM Fong, PT, PhD

Role: CONTACT

Phone: +85297090337

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shirley SM Fong, PT, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17120515

Identifier Type: -

Identifier Source: org_study_id